近日,第二军医大学东方肝胆外科研究所主任王红阳院士团队在肝炎—癌转化研究方面获得重大突破。研究成果发表在国际主流期刊《癌细胞》、《自然通讯》、《肝脏病学》等。肝癌的高发病率和高死亡率与肝炎高发密不可分,但对慢性肝炎发生和转归的分子机制认识严重不足,缺少有效干预和治疗手段,难以阻断 Recently, Wang Hongyang, director of the Institute of Oriental Hepatobiliary Surgery at the Second Military Medical University, made a major breakthrough in hepatitis-cancer transformation research. Research results published in the international mainstream journals “cancer cells”, “natural communication”, “liver disease” and so on. High incidence of liver cancer and high mortality and high incidence of hepatitis are inseparable, but the pathogenesis of chronic hepatitis and prognosis of the molecular mechanism of a serious lack of effective intervention and treatment is lacking, it is difficult to block